Since her graduate studies Dr. Emborg's research focus has been in understanding and finding solutions for neurodegenerative disorders, with emphasis on Parkinson’s disease. Her body of work includes nonhuman primate models of neurological disorders, gene and cell-based therapies for Parkinson’s and the development of conceptual frameworks for ethical clinical translation of novel treatments. In 2004, she became faculty at the University of Wisconsin, Madison, where today she is the Director of the Preclinical Parkinson’s Research Program at the Wisconsin National Primate Research Center, and a Professor of Medical Physics. She is Editor of Neuroscience and Tissue Engineering Section for Cell Transplantation, past President of the American Society for Neural Therapy and Repair and the 2016 recipient of the Bernard Sanberg Memorial Award for Brain Repair (http://www.eurekalert.org/pub_releases/2016-05/uosf-uow043016.php).
Marina Emborg, MD, PhD
Room 119 Primate
1220 Capitol Court
Madison, WI 53715
PhD, School of Medicine, Universidad de Buenos Aires
MD, School of Medicine, Universidad de Buenos Aires
Kimmelman, J., London, A., Emborg M.E. (2010) Beyond Access Vs. Protection in Trials of Innovative Therapies: Scientific Integrity as a Core Value in Research Ethics. Science 328: 829-830.
Kimmelman J., London A., Ravina B., Ramsay T., Bernstein M, Fine A, Stahnisch FW, Emborg M.E. (2009) Launching invasive, first-in-human trials against Parkinson’s disease: ethical considerations Mov Disord. 24:1893-1901. NIHMSID: NIHMS146175
Capitanio, J., & Emborg, M.E. (2008). Contributions of non human primate models to neuroscience research. Lancet, 371,1126-1135.
Emborg M.E. (2004) Evaluation of animal models of Parkinson’s disease for neuroprotective strategies. J. Neurosci. Methods 139: 121-143. *2004 most downloaded paper for Elsevier Neuroscience